Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06780423

Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Until now, cancer is still associated with high morbidity and mortality, and is therefore a big issue for the public health. Colorectal cancer is the second leading cause of cancer death in developed countries. In advanced colorectal cancer, 60% of these patients develop cachexia. The presence of cachexia plays an important role in the high mortality rate of cancer. Cachexia is characterized by involuntary weight loss with loss of skeletal muscle with or without loss of fat mass. The aim of this study is to determine the feasibility of taking muscle biopsies of cachectic colorectal cancer patients. Skeletal muscle characteristics will be compared between biopsies of the m. erector spinae and the m. vastus lateralis from cachectic colorectal cancer patients, non-cachectic colorectal cancer patients and healthy controls. 10 cachectic, 25 non-cachectic, and 25 healthy controls will be recruited for this study. It is an observational study, so measurements will be taken at one time point. Interventions/measurements: * muscle biopsies * blood samples * 3D freehand ultrasound * Short physical performance battery test * handgrip strength * questionnaires (activity pattern, quality of life)

Conditions

Interventions

TypeNameDescription
PROCEDUREMinimal invasive fine needle muscle biopsiesFine needle muscle biopsies will be taken from the m. erector spinae and the m. vastus lateralis. Participants are placed in a standardized prone position on the examination table for measurements of the m. erector spinae and in a supine position for measurements of the m. vastus lateralis.

Timeline

Start date
2022-01-23
Primary completion
2025-03-15
Completion
2025-09-10
First posted
2025-01-17
Last updated
2025-09-09

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06780423. Inclusion in this directory is not an endorsement.